Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Magnesium supplement shows promise for energy and mood in small trial

NCT ID NCT07398521

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a liposomal magnesium supplement in 60 adults who reported low energy and mood issues. Participants took the supplement daily for 14 days and filled out questionnaires about their energy, mood, and stress levels. The trial was small, short, and had no placebo group, so results are preliminary.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Liposomal Magnesium Complex (dietary supplement)
What this could lead to
If it works, this could point toward a simple supplement to help with low energy and mood issues.
What could go wrong
This is a small, short trial with no placebo group, so results may be due to expectation rather than the supplement. It does not test for long-term effects or serious conditions.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

60 people

The number who actually took part.

Started

Oct 2025

Finished

Dec 2025

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 60 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Be male or female * Be aged 18-60 * Anyone currently experiencing issues regarding all of the following: Low energy, Difficulty regulating mood * Anyone who is generally healthy - does not live with any uncontrolled chronic disease. * Anyone willing to avoid all other dietary supplements or products containing magnesium for the duration of the trial. * Anyone willing to refrain from taking any products, prescription medications, or supplements that target energy, mood, stress, and sleep during the test period. * Anyone willing to maintain their current diet, sleep schedule, and activity level for the duration of the study. * Resides in the United States. Exclusion Criteria: * Anyone with pre-existing chronic conditions that would prevent participants from adhering to the protocol, including cancer and mental health disorders. * Anyone with a nut allergy or allergies or sensitivities to any of the product ingredients. * Any women who are pregnant, breastfeeding, or trying to conceive (or who will be at any point during the study period). * Anyone who drinks heavily (i.e., 8 or more alcoholic drinks per week for women or 15 or more alcoholic drinks per week for men). * History of diagnosed psychiatric or mood disorders. * History of diagnosed sleep disorders. * History of serious illness in the last three months. * History of substance abuse. * History of kidney disease. * History of hormone or endocrine disorders, including but not limited to hypothyroidism, Hashimoto's thyroiditis, polycystic ovarian syndrome (PCOS), and diabetes. * Planned surgery during the study period. * Currently partaking in another research study or will be partaking in any other research study for the next 2 weeks, or at any point during this study's duration. * Anyone unwilling to follow the study protocol.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MOOD are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Citruslabs

    Las Vegas, Nevada, 89118, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.